Works matching IS 15228517 AND DT 2016 AND VI 18 AND IP 9

Results: 20

Response to: “Prognostic relevance of epilepsy at presentation in lower-grade gliomas”.

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1327, doi. 10.1093/neuonc/now161

By:

Berendsen, Sharon;
Snijders, Tom J.;
Robe, Pierre A.

Publication type:

Article

Highlights from the Literature.

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1195, doi. 10.1093/neuonc/now173

By:

Lawler, Sean;
Schiff, David;
Wick, Wolfgang;
Chamberlain, Marc;
Wright, Karen

Publication type:

Article

Corrigendum.

Published in:: Neuro-Oncology, 2016, v. 18, n. 9, p. 1329, doi. 10.1093/neuonc/now142
Publication type:: Article

Announcements.

Published in:: Neuro-Oncology, 2016, v. 18, n. 9, p. 1330, doi. 10.1093/neuonc/now172
Publication type:: Article

Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1253, doi. 10.1093/neuonc/now034

By:

Gielen, Paul R.;
Schulte, Barbara M.;
Kers-Rebel, Esther D.;
Verrijp, Kiek;
Bossman, Sandra A. J. F. H.;
Laan, Mark ter;
Wesseling, Pieter;
Adema, Gosse J.

Publication type:

Article

A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus.

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1278, doi. 10.1093/neuonc/now031

By:

Nigim, Fares;
Esaki, Shin-ichi;
Hood, Michael;
Lelic, Nina;
James, Marianne F.;
Ramesh, Vijaya;
Stemmer-Rachamimov, Anat;
Cahill, Daniel P.;
Brastianos, Priscilla K.;
Rabkin, Samuel D.;
Martuza, Robert L.;
Wakimoto, Hiroaki

Publication type:

Article

Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo.

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1242, doi. 10.1093/neuonc/now043

By:

Szabo, Emese;
Schneider, Hannah;
Seystahl, Katharina;
Rushing, Elisabeth Jane;
Herting, Frank;
Weidner, K. Michael;
Weller, Michael

Publication type:

Article

Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation.

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1219, doi. 10.1093/neuonc/now024

By:

Kathagen-Buhmann, Annegret;
Schulte, Alexander;
Weller, Jonathan;
Holz, Mareike;
Herold-Mende, Christel;
Glass, Rainer;
Lamszus, Katrin

Publication type:

Article

Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients.

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1209, doi. 10.1093/neuonc/now051

By:

LeBlanc, Amy K.;
Mazcko, Christina;
Brown, Diane E.;
Koehler, Jennifer W.;
Miller, Andrew D.;
Miller, C. Ryan;
Bentley, R. Timothy;
Packer, Rebecca A.;
Breen, Matthew;
Boudreau, C. Elizabeth;
Levine, Jonathan M.;
Simpson, R. Mark;
Halsey, Charles;
Kisseberth, William;
Rossmeisl Jr., John H.;
Dickinson, Peter J.;
Fan, Timothy M.;
Corps, Kara;
Aldape, Kenneth;
Puduvalli, Vinay

Publication type:

Article

Prognostic relevance of epilepsy at presentation in lower-grade gliomas.

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1326, doi. 10.1093/neuonc/now140

By:

Hao Zhou;
Xiangyan Huang;
Bai, Harrison X.;
Xia Tan;
Bo Xiao;
Li Yang;
Berendsen, Sharon;
Snijders, Tom J.;
Robe, Pierre A.

Publication type:

Article

Phase 1 trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study.

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1319, doi. 10.1093/neuonc/now047

By:

Lulla, Rishi R.;
Goldman, Stewart;
Tohru Yamada;
Beattie, Craig W.;
Bressler, Linda;
Pacini, Michael;
Pollack, Ian F.;
Fisher, Paul Graham;
Packer, Roger J.;
Dunkel, Ira J.;
Dhall, Girish;
Shengjie Wu;
Onar, Arzu;
Boyett, James M.;
Fouladi, Maryam

Publication type:

Article

Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio.

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1313, doi. 10.1093/neuonc/now046

By:

Chinot, Olivier L.;
Nishikawa, Ryo;
Mason, Warren;
Henriksson, Roger;
Saran, Frank;
Cloughesy, Timothy;
Garcia, Josep;
Revil, Cedric;
Abrey, Lauren;
Wick, Wolfgang

Publication type:

Article

AVAREG: a phase 2, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma.

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1304, doi. 10.1093/neuonc/now035

By:

Brandes, Alba A.;
Finocchiaro, Gaetano;
Zagonel, Vittorina;
Reni, Michele;
Caserta, Claudia;
Fabi, Alessandra;
Clavarezza, Matteo;
Maiello, Evaristo;
Eoli, Marica;
Lombardi, Giuseppe;
Monteforte, Marta;
Proietti, Emanuela;
Agati, Raffaele;
Eusebi, Vincenzo;
Franceschi, Enrico

Publication type:

Article

Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1297, doi. 10.1093/neuonc/now033

By:

Langner-Lemercier, Sophie;
Houillier, Caroline;
Soussain, Carole;
Ghesquières, Hervé;
Chinot, Olivier;
Taillandier, Luc;
Soubeyran, Pierre;
Lamy, Thierry;
Morschhauser, Franck;
Benouaich-Amiel, Alexandra;
Ahle, Guido;
Moles-Moreau, Marie-Pierre;
Moluçon-Chabrot, Cécile;
Bourquard, Pascal;
Damaj, Ghandi;
Jardin, Fabrice;
Larrieu, Delphine;
Gyan, Emmanuel;
Gressin, Remy;
Jaccard, Arnaud

Publication type:

Article

MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7.

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1288, doi. 10.1093/neuonc/now044

By:

Xiao Yue;
Dechen Cao;
FengMing Lan;
Qiang Pan;
Tingyi Xia;
Huiming Yu

Publication type:

Article

Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas.

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1265, doi. 10.1093/neuonc/now032

By:

Oblinger, Janet L.;
Burns, Sarah S.;
Akhmametyeva, Elena M.;
Jie Huang;
Li Pan;
Yulin Ren;
Rulong Shen;
Miles-Markley, Beth;
Moberly, Aaron C.;
Kinghorn, A. Douglas;
Welling, D. Bradley;
Long-Sheng Chang

Publication type:

Article

PET imaging in glioma: is it time for mainstream practice?

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1193, doi. 10.1093/neuonc/now134

By:

Watts, Colin;
Langen, Karl-Josef

Publication type:

Article

Corticosteroids for peritumoral edema: time to overcome our addiction?

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1191, doi. 10.1093/neuonc/now167

By:

Lee, Eudocia Q.;
Wen, Patrick Y.

Publication type:

Article

Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models.

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1230, doi. 10.1093/neuonc/now030

By:

Yuji Piao;
Soon Young Park;
Henry, Verlene;
Smith, Bryan D.;
Ningyi Tiao;
Flynn, Daniel L.;
de Groot, John F.

Publication type:

Article

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1199, doi. 10.1093/neuonc/now058

By:

Albert, Nathalie L.;
Weller, Michael;
Suchorska, Bogdana;
Galldiks, Norbert;
Soffietti, Riccardo;
Kim, Michelle M.;
la Fougère, Christian;
Pope, Whitney;
Law, Ian;
Arbizu, Javier;
Chamberlain, Marc C.;
Vogelbaum, Michael;
Ellingson, Ben M.;
Tonn, Joerg C.

Publication type:

Article